摘要
甲状腺癌是最常见的内分泌肿瘤,虽死亡率不高,但发病率逐年上升。PET/CT在协助甲状腺癌诊断、分期、治疗后疗效评价及预后评估等方面具有重要临床应用价值。近年,^(18)F-FDG及多种新型显像剂的出现,在各种病理分型的甲状腺癌治疗方案选择及患者预后评估中起到重要作用。
Thyroid cancer is the most common malignant of the endocrine system. Although the mortality is not high,the incidence is raised year by year. PET/CT plays an important role in diagnosis,staging,response evaluation after treatment andprognosis evaluation of thyroid cancer In recent years,the emergence of ^（18）F-FDG and a variety of new imaging agents play a dominant role in the selection of therapeutic scheme and assessment the prognosis of different pathological type of thyroid cancer.
出处
《肿瘤学杂志》
CAS
2017年第6期470-473,共4页
Journal of Chinese Oncology
基金
国家重大科学仪器设备开发专项(2011YQ03011409)
十二五国家支撑项目基金(2014BAA03B03)
